MAPT and Alzheimer disease: Personalized brain modeling and neuroimaging studies have revealed that GABAergic signaling significantly influences cognitive executive function in Alzheimer’s disease (AD), while glutamatergic and cholinergic systems modulate the distribution of amyloid-β and tau pathology (Khan et al., 2022).